ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma

BACKGROUND: Activating transcription factor 2 (ATF2) is a basic helix-loop-helix transcription factor, which has been shown to participate in the pathobiology of numerous cancers. However, the role of ATF2 in renal cell carcinoma (RCC) remains unclear. METHODS: ATF2 knockdown and overexpression stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Deng-shuang, Chen, Cheng, Wu, Zhen-jie, Liu, Bing, Gao, Li, Yang, Qing, Chen, Wei, Chen, Jun-ming, Bao, Yi, Qu, Le, Wang, Lin-hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932740/
https://www.ncbi.nlm.nih.gov/pubmed/27377902
http://dx.doi.org/10.1186/s13046-016-0383-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932740/
https://www.ncbi.nlm.nih.gov/pubmed/27377902
http://dx.doi.org/10.1186/s13046-016-0383-2

Ejemplares similares